nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—FPR1—renal system—colon cancer	0.0335	0.0758	CbGeAlD
Nedocromil—HSP90AA1—endothelium—colon cancer	0.0292	0.0661	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—colon cancer	0.0278	0.063	CbGeAlD
Nedocromil—FPR1—digestive system—colon cancer	0.0275	0.0622	CbGeAlD
Nedocromil—HSP90AA1—blood vessel—colon cancer	0.0269	0.0609	CbGeAlD
Nedocromil—PTGDR—digestive system—colon cancer	0.026	0.0587	CbGeAlD
Nedocromil—FPR1—bone marrow—colon cancer	0.0253	0.0573	CbGeAlD
Nedocromil—HSP90AA1—gall bladder—colon cancer	0.0253	0.0573	CbGeAlD
Nedocromil—PTGDR—bone marrow—colon cancer	0.0239	0.0542	CbGeAlD
Nedocromil—PTGDR—vagina—colon cancer	0.0229	0.0519	CbGeAlD
Nedocromil—HSP90AA1—embryo—colon cancer	0.0161	0.0363	CbGeAlD
Nedocromil—PTGDR—lymph node—colon cancer	0.0148	0.0336	CbGeAlD
Nedocromil—CYSLTR1—smooth muscle tissue—colon cancer	0.0146	0.0329	CbGeAlD
Nedocromil—HSP90AA1—epithelium—colon cancer	0.0131	0.0297	CbGeAlD
Nedocromil—HSP90AA1—smooth muscle tissue—colon cancer	0.0126	0.0286	CbGeAlD
Nedocromil—HSP90AA1—renal system—colon cancer	0.0122	0.0275	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—colon cancer	0.0116	0.0263	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—colon cancer	0.0106	0.024	CbGeAlD
Nedocromil—CYSLTR1—vagina—colon cancer	0.0101	0.023	CbGeAlD
Nedocromil—HSP90AA1—lymphoid tissue—colon cancer	0.0101	0.0228	CbGeAlD
Nedocromil—HSP90AA1—digestive system—colon cancer	0.00997	0.0226	CbGeAlD
Nedocromil—HSP90AA1—bone marrow—colon cancer	0.00919	0.0208	CbGeAlD
Nedocromil—HSP90AA1—vagina—colon cancer	0.0088	0.0199	CbGeAlD
Nedocromil—HSP90AA1—liver—colon cancer	0.00743	0.0168	CbGeAlD
Nedocromil—CYSLTR1—lymph node—colon cancer	0.00656	0.0149	CbGeAlD
Nedocromil—HSP90AA1—lymph node—colon cancer	0.00569	0.0129	CbGeAlD
Nedocromil—Disorder sight—Capecitabine—colon cancer	0.00477	0.0328	CcSEcCtD
Nedocromil—Stinging—Fluorouracil—colon cancer	0.00401	0.0276	CcSEcCtD
Nedocromil—Cough increased—Irinotecan—colon cancer	0.00371	0.0255	CcSEcCtD
Nedocromil—Photophobia—Fluorouracil—colon cancer	0.00305	0.021	CcSEcCtD
Nedocromil—Rash erythematous—Capecitabine—colon cancer	0.00297	0.0204	CcSEcCtD
Nedocromil—Otitis media—Capecitabine—colon cancer	0.00292	0.0201	CcSEcCtD
Nedocromil—Dysphonia—Capecitabine—colon cancer	0.00276	0.019	CcSEcCtD
Nedocromil—Eosinophilia—Fluorouracil—colon cancer	0.00202	0.0139	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Irinotecan—colon cancer	0.00198	0.0136	CcSEcCtD
Nedocromil—Pneumonia—Vincristine—colon cancer	0.00196	0.0135	CcSEcCtD
Nedocromil—Ear pain—Capecitabine—colon cancer	0.00193	0.0133	CcSEcCtD
Nedocromil—Pneumonia—Irinotecan—colon cancer	0.00191	0.0131	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Fluorouracil—colon cancer	0.0019	0.013	CcSEcCtD
Nedocromil—Gastroenteritis—Capecitabine—colon cancer	0.00186	0.0128	CcSEcCtD
Nedocromil—Pneumonia—Fluorouracil—colon cancer	0.00183	0.0126	CcSEcCtD
Nedocromil—Conjunctivitis—Fluorouracil—colon cancer	0.00177	0.0122	CcSEcCtD
Nedocromil—Rhinitis—Irinotecan—colon cancer	0.00171	0.0117	CcSEcCtD
Nedocromil—Sinusitis—Fluorouracil—colon cancer	0.00171	0.0117	CcSEcCtD
Nedocromil—Arthritis—Capecitabine—colon cancer	0.0017	0.0117	CcSEcCtD
Nedocromil—Visual impairment—Irinotecan—colon cancer	0.00164	0.0113	CcSEcCtD
Nedocromil—Rhinitis—Fluorouracil—colon cancer	0.00164	0.0113	CcSEcCtD
Nedocromil—Pharyngitis—Fluorouracil—colon cancer	0.00162	0.0111	CcSEcCtD
Nedocromil—Influenza—Capecitabine—colon cancer	0.00143	0.0098	CcSEcCtD
Nedocromil—Bronchitis—Capecitabine—colon cancer	0.00137	0.00942	CcSEcCtD
Nedocromil—Leukopenia—Vincristine—colon cancer	0.00136	0.00938	CcSEcCtD
Nedocromil—Leukopenia—Irinotecan—colon cancer	0.00133	0.00913	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Capecitabine—colon cancer	0.00133	0.00911	CcSEcCtD
Nedocromil—Cough—Irinotecan—colon cancer	0.0013	0.0089	CcSEcCtD
Nedocromil—Pneumonia—Capecitabine—colon cancer	0.00128	0.00879	CcSEcCtD
Nedocromil—Leukopenia—Fluorouracil—colon cancer	0.00127	0.00875	CcSEcCtD
Nedocromil—Anaphylactic shock—Vincristine—colon cancer	0.00124	0.00855	CcSEcCtD
Nedocromil—Conjunctivitis—Capecitabine—colon cancer	0.00124	0.00849	CcSEcCtD
Nedocromil—Anaphylactic shock—Irinotecan—colon cancer	0.00121	0.00833	CcSEcCtD
Nedocromil—Chest pain—Fluorouracil—colon cancer	0.00121	0.00832	CcSEcCtD
Nedocromil—Anaphylactic shock—Fluorouracil—colon cancer	0.00116	0.00797	CcSEcCtD
Nedocromil—Rhinitis—Capecitabine—colon cancer	0.00114	0.00786	CcSEcCtD
Nedocromil—Pharyngitis—Capecitabine—colon cancer	0.00113	0.00778	CcSEcCtD
Nedocromil—Visual impairment—Capecitabine—colon cancer	0.0011	0.00756	CcSEcCtD
Nedocromil—Dyspnoea—Irinotecan—colon cancer	0.00108	0.00742	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Vincristine—colon cancer	0.00107	0.00738	CcSEcCtD
Nedocromil—Fatigue—Vincristine—colon cancer	0.00107	0.00737	CcSEcCtD
Nedocromil—Dyspepsia—Irinotecan—colon cancer	0.00107	0.00733	CcSEcCtD
Nedocromil—Pain—Vincristine—colon cancer	0.00106	0.00731	CcSEcCtD
Nedocromil—Eosinophilia—Methotrexate—colon cancer	0.00105	0.00722	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Irinotecan—colon cancer	0.00105	0.00719	CcSEcCtD
Nedocromil—Fatigue—Irinotecan—colon cancer	0.00104	0.00718	CcSEcCtD
Nedocromil—Pain—Irinotecan—colon cancer	0.00104	0.00712	CcSEcCtD
Nedocromil—Dyspnoea—Fluorouracil—colon cancer	0.00103	0.00711	CcSEcCtD
Nedocromil—Dyspepsia—Fluorouracil—colon cancer	0.00102	0.00702	CcSEcCtD
Nedocromil—Gastrointestinal pain—Vincristine—colon cancer	0.00102	0.00699	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.001	0.00688	CcSEcCtD
Nedocromil—Pain—Fluorouracil—colon cancer	0.000992	0.00682	CcSEcCtD
Nedocromil—Gastrointestinal pain—Irinotecan—colon cancer	0.000991	0.00681	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Methotrexate—colon cancer	0.000987	0.00678	CcSEcCtD
Nedocromil—Abdominal pain—Vincristine—colon cancer	0.000983	0.00676	CcSEcCtD
Nedocromil—Body temperature increased—Vincristine—colon cancer	0.000983	0.00676	CcSEcCtD
Nedocromil—Dysgeusia—Capecitabine—colon cancer	0.000973	0.00669	CcSEcCtD
Nedocromil—Abdominal pain—Irinotecan—colon cancer	0.000958	0.00658	CcSEcCtD
Nedocromil—Body temperature increased—Irinotecan—colon cancer	0.000958	0.00658	CcSEcCtD
Nedocromil—Pneumonia—Methotrexate—colon cancer	0.000952	0.00654	CcSEcCtD
Nedocromil—Tremor—Capecitabine—colon cancer	0.000931	0.0064	CcSEcCtD
Nedocromil—Urticaria—Fluorouracil—colon cancer	0.000922	0.00633	CcSEcCtD
Nedocromil—Conjunctivitis—Methotrexate—colon cancer	0.00092	0.00632	CcSEcCtD
Nedocromil—Body temperature increased—Fluorouracil—colon cancer	0.000917	0.0063	CcSEcCtD
Nedocromil—Hypersensitivity—Vincristine—colon cancer	0.000917	0.0063	CcSEcCtD
Nedocromil—Hypersensitivity—Irinotecan—colon cancer	0.000893	0.00613	CcSEcCtD
Nedocromil—Asthenia—Vincristine—colon cancer	0.000893	0.00613	CcSEcCtD
Nedocromil—Leukopenia—Capecitabine—colon cancer	0.000889	0.00611	CcSEcCtD
Nedocromil—Asthenia—Irinotecan—colon cancer	0.000869	0.00597	CcSEcCtD
Nedocromil—Cough—Capecitabine—colon cancer	0.000867	0.00596	CcSEcCtD
Nedocromil—Hypersensitivity—Fluorouracil—colon cancer	0.000855	0.00587	CcSEcCtD
Nedocromil—Diarrhoea—Vincristine—colon cancer	0.000851	0.00585	CcSEcCtD
Nedocromil—Chest pain—Capecitabine—colon cancer	0.000846	0.00581	CcSEcCtD
Nedocromil—Pharyngitis—Methotrexate—colon cancer	0.000843	0.00579	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—LGR5—colon cancer	0.000834	0.00202	CbGpPWpGaD
Nedocromil—Diarrhoea—Irinotecan—colon cancer	0.000829	0.0057	CcSEcCtD
Nedocromil—Dry mouth—Capecitabine—colon cancer	0.000827	0.00568	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—colon cancer	0.000826	0.002	CbGpPWpGaD
Nedocromil—Dizziness—Vincristine—colon cancer	0.000823	0.00565	CcSEcCtD
Nedocromil—Visual impairment—Methotrexate—colon cancer	0.000819	0.00563	CcSEcCtD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	0.000807	0.00196	CbGpPWpGaD
Nedocromil—Dizziness—Irinotecan—colon cancer	0.000801	0.00551	CcSEcCtD
Nedocromil—Diarrhoea—Fluorouracil—colon cancer	0.000794	0.00546	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—colon cancer	0.000792	0.00192	CbGpPWpGaD
Nedocromil—Vomiting—Vincristine—colon cancer	0.000791	0.00544	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—BUB1B—colon cancer	0.000786	0.0019	CbGpPWpGaD
Nedocromil—Rash—Vincristine—colon cancer	0.000784	0.00539	CcSEcCtD
Nedocromil—Dermatitis—Vincristine—colon cancer	0.000784	0.00539	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—KRAS—colon cancer	0.00078	0.00189	CbGpPWpGaD
Nedocromil—Headache—Vincristine—colon cancer	0.000779	0.00536	CcSEcCtD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—colon cancer	0.000779	0.00189	CbGpPWpGaD
Nedocromil—Vomiting—Irinotecan—colon cancer	0.00077	0.00529	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—CDKN1A—colon cancer	0.00077	0.00187	CbGpPWpGaD
Nedocromil—Dizziness—Fluorouracil—colon cancer	0.000767	0.00527	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.000767	0.00186	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	0.000765	0.00185	CbGpPWpGaD
Nedocromil—Rash—Irinotecan—colon cancer	0.000764	0.00525	CcSEcCtD
Nedocromil—Dermatitis—Irinotecan—colon cancer	0.000763	0.00524	CcSEcCtD
Nedocromil—Headache—Irinotecan—colon cancer	0.000759	0.00522	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—PIK3CA—colon cancer	0.000759	0.00184	CbGpPWpGaD
Nedocromil—Nausea—Vincristine—colon cancer	0.000739	0.00508	CcSEcCtD
Nedocromil—Vomiting—Fluorouracil—colon cancer	0.000738	0.00507	CcSEcCtD
Nedocromil—Rash—Fluorouracil—colon cancer	0.000732	0.00503	CcSEcCtD
Nedocromil—Dermatitis—Fluorouracil—colon cancer	0.000731	0.00502	CcSEcCtD
Nedocromil—Headache—Fluorouracil—colon cancer	0.000727	0.005	CcSEcCtD
Nedocromil—Dysgeusia—Methotrexate—colon cancer	0.000724	0.00498	CcSEcCtD
Nedocromil—Dyspnoea—Capecitabine—colon cancer	0.000723	0.00497	CcSEcCtD
Nedocromil—Nausea—Irinotecan—colon cancer	0.00072	0.00495	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—PIK3CA—colon cancer	0.000716	0.00174	CbGpPWpGaD
Nedocromil—HSP90AA1—Influenza Infection—TGFB1—colon cancer	0.000715	0.00173	CbGpPWpGaD
Nedocromil—Dyspepsia—Capecitabine—colon cancer	0.000714	0.0049	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—SRC—colon cancer	0.000712	0.00173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—CDKN1A—colon cancer	0.000708	0.00172	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—colon cancer	0.000702	0.0017	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Capecitabine—colon cancer	0.0007	0.00481	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—AKT1—colon cancer	0.000699	0.00169	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—AKT1—colon cancer	0.000699	0.00169	CbGpPWpGaD
Nedocromil—Fatigue—Capecitabine—colon cancer	0.000699	0.0048	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	0.000697	0.00169	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—TGFB1—colon cancer	0.000695	0.00169	CbGpPWpGaD
Nedocromil—Pain—Capecitabine—colon cancer	0.000693	0.00476	CcSEcCtD
Nedocromil—Nausea—Fluorouracil—colon cancer	0.000689	0.00474	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—NRAS—colon cancer	0.000685	0.00166	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—PIK3CA—colon cancer	0.000676	0.00164	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—TYMS—colon cancer	0.000674	0.00163	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Capecitabine—colon cancer	0.000663	0.00456	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—colon cancer	0.000663	0.00161	CbGpPWpGaD
Nedocromil—Leukopenia—Methotrexate—colon cancer	0.000662	0.00455	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	0.000658	0.0016	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—SRC—colon cancer	0.000655	0.00159	CbGpPWpGaD
Nedocromil—Cough—Methotrexate—colon cancer	0.000645	0.00444	CcSEcCtD
Nedocromil—Urticaria—Capecitabine—colon cancer	0.000644	0.00443	CcSEcCtD
Nedocromil—Body temperature increased—Capecitabine—colon cancer	0.000641	0.0044	CcSEcCtD
Nedocromil—Abdominal pain—Capecitabine—colon cancer	0.000641	0.0044	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—NRAS—colon cancer	0.00063	0.00153	CbGpPWpGaD
Nedocromil—Chest pain—Methotrexate—colon cancer	0.00063	0.00433	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—colon cancer	0.000624	0.00151	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—colon cancer	0.00062	0.0015	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	0.000605	0.00147	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Methotrexate—colon cancer	0.000604	0.00415	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—TYMS—colon cancer	0.000603	0.00146	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AXIN2—colon cancer	0.000599	0.00145	CbGpPWpGaD
Nedocromil—Hypersensitivity—Capecitabine—colon cancer	0.000597	0.00411	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—BCL10—colon cancer	0.000597	0.00145	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KRAS—colon cancer	0.00059	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—AKT1—colon cancer	0.000585	0.00142	CbGpPWpGaD
Nedocromil—Asthenia—Capecitabine—colon cancer	0.000582	0.004	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—colon cancer	0.000574	0.00139	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	0.00056	0.00136	CbGpPWpGaD
Nedocromil—Diarrhoea—Capecitabine—colon cancer	0.000555	0.00381	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KRAS—colon cancer	0.000542	0.00131	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—PIK3CA—colon cancer	0.000542	0.00131	CbGpPWpGaD
Nedocromil—Dyspnoea—Methotrexate—colon cancer	0.000538	0.0037	CcSEcCtD
Nedocromil—Dizziness—Capecitabine—colon cancer	0.000536	0.00368	CcSEcCtD
Nedocromil—Dyspepsia—Methotrexate—colon cancer	0.000531	0.00365	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN1A—colon cancer	0.000523	0.00127	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000521	0.00358	CcSEcCtD
Nedocromil—Fatigue—Methotrexate—colon cancer	0.00052	0.00358	CcSEcCtD
Nedocromil—Pain—Methotrexate—colon cancer	0.000516	0.00355	CcSEcCtD
Nedocromil—Vomiting—Capecitabine—colon cancer	0.000516	0.00354	CcSEcCtD
Nedocromil—Rash—Capecitabine—colon cancer	0.000511	0.00351	CcSEcCtD
Nedocromil—Dermatitis—Capecitabine—colon cancer	0.000511	0.00351	CcSEcCtD
Nedocromil—Headache—Capecitabine—colon cancer	0.000508	0.00349	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—colon cancer	0.000501	0.00121	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—colon cancer	0.000498	0.00121	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—EP300—colon cancer	0.000498	0.00121	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Methotrexate—colon cancer	0.000494	0.00339	CcSEcCtD
Nedocromil—Nausea—Capecitabine—colon cancer	0.000482	0.00331	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—BCL2L1—colon cancer	0.000481	0.00116	CbGpPWpGaD
Nedocromil—Urticaria—Methotrexate—colon cancer	0.00048	0.0033	CcSEcCtD
Nedocromil—Body temperature increased—Methotrexate—colon cancer	0.000477	0.00328	CcSEcCtD
Nedocromil—Abdominal pain—Methotrexate—colon cancer	0.000477	0.00328	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—VEGFA—colon cancer	0.000472	0.00114	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—PPARG—colon cancer	0.000461	0.00112	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—colon cancer	0.000461	0.00112	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—FGFR3—colon cancer	0.00046	0.00111	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FGFR3—colon cancer	0.000459	0.00111	CbGpPWpGaD
Nedocromil—Hypersensitivity—Methotrexate—colon cancer	0.000445	0.00306	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—FGFR3—colon cancer	0.000443	0.00107	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—colon cancer	0.000443	0.00107	CbGpPWpGaD
Nedocromil—Asthenia—Methotrexate—colon cancer	0.000433	0.00298	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—APC—colon cancer	0.000421	0.00102	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—NRAS—colon cancer	0.000421	0.00102	CbGpPWpGaD
Nedocromil—Diarrhoea—Methotrexate—colon cancer	0.000413	0.00284	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—SRC—colon cancer	0.000411	0.000996	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—colon cancer	0.000407	0.000986	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—APC—colon cancer	0.000407	0.000986	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—NRAS—colon cancer	0.000407	0.000986	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—colon cancer	0.0004	0.00097	CbGpPWpGaD
Nedocromil—Dizziness—Methotrexate—colon cancer	0.000399	0.00274	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—BRAF—colon cancer	0.000396	0.00096	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—NRAS—colon cancer	0.000395	0.000958	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—colon cancer	0.000384	0.00093	CbGpPWpGaD
Nedocromil—Vomiting—Methotrexate—colon cancer	0.000384	0.00264	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—BRAF—colon cancer	0.000383	0.000927	CbGpPWpGaD
Nedocromil—Rash—Methotrexate—colon cancer	0.000381	0.00262	CcSEcCtD
Nedocromil—Dermatitis—Methotrexate—colon cancer	0.00038	0.00261	CcSEcCtD
Nedocromil—Headache—Methotrexate—colon cancer	0.000378	0.0026	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—colon cancer	0.000371	0.000898	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—PIK3CA—colon cancer	0.000367	0.000889	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—KRAS—colon cancer	0.000363	0.000879	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—colon cancer	0.00036	0.000873	CbGpPWpGaD
Nedocromil—Nausea—Methotrexate—colon cancer	0.000359	0.00246	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—colon cancer	0.000356	0.000864	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—PIK3CA—colon cancer	0.000354	0.000859	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—KRAS—colon cancer	0.00035	0.000849	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGFR3—colon cancer	0.000348	0.000843	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—KRAS—colon cancer	0.00034	0.000825	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—colon cancer	0.000339	0.000822	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—PIK3CA—colon cancer	0.000333	0.000807	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN1A—colon cancer	0.000328	0.000795	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD8A—colon cancer	0.000327	0.000793	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CTNNB1—colon cancer	0.000325	0.000786	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—PIK3CA—colon cancer	0.000322	0.00078	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APC—colon cancer	0.000319	0.000774	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—NRAS—colon cancer	0.000319	0.000774	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—EP300—colon cancer	0.000312	0.000757	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—colon cancer	0.000308	0.000747	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—colon cancer	0.000303	0.000735	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EP300—colon cancer	0.000302	0.000731	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—BRAF—colon cancer	0.0003	0.000727	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—colon cancer	0.0003	0.000726	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—colon cancer	0.000298	0.000721	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—colon cancer	0.000297	0.00072	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN1A—colon cancer	0.000294	0.000711	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SRC—colon cancer	0.000293	0.000711	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—colon cancer	0.000291	0.000705	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—colon cancer	0.000289	0.000702	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—colon cancer	0.000289	0.000701	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—colon cancer	0.000289	0.0007	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—colon cancer	0.000287	0.000695	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTNNB1—colon cancer	0.000287	0.000695	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CTNNB1—colon cancer	0.000286	0.000694	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—colon cancer	0.000286	0.000692	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NRAS—colon cancer	0.000282	0.000684	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDKN1A—colon cancer	0.00028	0.000679	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2L1—colon cancer	0.00028	0.000678	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN1A—colon cancer	0.00028	0.000678	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—EP300—colon cancer	0.000279	0.000677	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—colon cancer	0.000279	0.000677	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—colon cancer	0.000278	0.000674	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CTNNB1—colon cancer	0.000276	0.00067	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—KRAS—colon cancer	0.000275	0.000666	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—colon cancer	0.000272	0.00066	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—colon cancer	0.000272	0.00066	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN1A—colon cancer	0.00027	0.000654	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGFR3—colon cancer	0.000268	0.000649	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EP300—colon cancer	0.000266	0.000646	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EP300—colon cancer	0.000266	0.000645	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCB1—colon cancer	0.000264	0.000639	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—colon cancer	0.000263	0.000637	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—colon cancer	0.000262	0.000635	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—SRC—colon cancer	0.000259	0.000628	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TYMS—colon cancer	0.000259	0.000627	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SRC—colon cancer	0.000259	0.000627	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—colon cancer	0.000257	0.000623	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EP300—colon cancer	0.000257	0.000623	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—colon cancer	0.000253	0.000612	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—colon cancer	0.000252	0.000611	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SRC—colon cancer	0.00025	0.000606	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NRAS—colon cancer	0.000249	0.000604	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NRAS—colon cancer	0.000249	0.000603	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGFR3—colon cancer	0.000247	0.000599	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—colon cancer	0.000243	0.00059	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—colon cancer	0.000243	0.00059	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KRAS—colon cancer	0.000243	0.000589	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGFR3—colon cancer	0.000241	0.000584	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NRAS—colon cancer	0.00024	0.000583	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—colon cancer	0.000234	0.000566	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—colon cancer	0.000232	0.000562	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—colon cancer	0.000231	0.000561	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—colon cancer	0.000227	0.00055	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—colon cancer	0.000227	0.00055	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APC—colon cancer	0.000227	0.00055	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—colon cancer	0.000227	0.00055	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDH1—colon cancer	0.000226	0.000548	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—colon cancer	0.000225	0.000545	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—colon cancer	0.000224	0.000543	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—colon cancer	0.000223	0.000541	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APC—colon cancer	0.000221	0.000536	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—NRAS—colon cancer	0.000221	0.000536	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—colon cancer	0.000219	0.000531	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—colon cancer	0.000219	0.000531	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CTNNB1—colon cancer	0.000217	0.000526	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KRAS—colon cancer	0.000215	0.00052	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KRAS—colon cancer	0.000214	0.000519	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BRAF—colon cancer	0.000213	0.000517	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN1A—colon cancer	0.000212	0.000514	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BRAF—colon cancer	0.000208	0.000504	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KRAS—colon cancer	0.000207	0.000501	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—colon cancer	0.000206	0.0005	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—colon cancer	0.000206	0.0005	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—colon cancer	0.000202	0.000489	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EP300—colon cancer	0.000202	0.000489	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—colon cancer	0.0002	0.000484	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—colon cancer	0.000197	0.000478	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—colon cancer	0.000197	0.000477	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SRC—colon cancer	0.000196	0.000475	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—colon cancer	0.000193	0.000467	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—colon cancer	0.000191	0.000463	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KRAS—colon cancer	0.000191	0.000462	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—colon cancer	0.00019	0.000461	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—colon cancer	0.00019	0.000461	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NRAS—colon cancer	0.000189	0.000457	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—colon cancer	0.000184	0.000446	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—colon cancer	0.000183	0.000444	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—colon cancer	0.000182	0.000442	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—colon cancer	0.000182	0.000442	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—colon cancer	0.000182	0.000441	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—colon cancer	0.000176	0.000426	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—colon cancer	0.000176	0.000426	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—colon cancer	0.000175	0.000425	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—colon cancer	0.000175	0.000424	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGFR3—colon cancer	0.000173	0.000419	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—colon cancer	0.000172	0.000417	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—colon cancer	0.000172	0.000416	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTNNB1—colon cancer	0.000167	0.000405	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDKN1A—colon cancer	0.000163	0.000395	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KRAS—colon cancer	0.000162	0.000393	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—colon cancer	0.000162	0.000392	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—colon cancer	0.000161	0.00039	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—colon cancer	0.000161	0.00039	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APC—colon cancer	0.000159	0.000385	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—colon cancer	0.000157	0.000382	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—colon cancer	0.000156	0.000378	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—colon cancer	0.000155	0.000376	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EP300—colon cancer	0.000155	0.000376	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CTNNB1—colon cancer	0.000154	0.000374	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—colon cancer	0.000152	0.000368	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SRC—colon cancer	0.000151	0.000366	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN1A—colon cancer	0.000151	0.000365	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CTNNB1—colon cancer	0.00015	0.000364	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BRAF—colon cancer	0.000149	0.000362	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—colon cancer	0.000149	0.000361	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN1A—colon cancer	0.000147	0.000356	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NRAS—colon cancer	0.000145	0.000352	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—colon cancer	0.000144	0.00035	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—colon cancer	0.000144	0.00035	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EP300—colon cancer	0.000143	0.000347	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—colon cancer	0.000143	0.000346	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EP300—colon cancer	0.00014	0.000339	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SRC—colon cancer	0.000139	0.000338	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—colon cancer	0.000138	0.000334	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SRC—colon cancer	0.000136	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NRAS—colon cancer	0.000134	0.000325	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—colon cancer	0.000132	0.000321	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—colon cancer	0.000132	0.000321	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NRAS—colon cancer	0.000131	0.000317	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KRAS—colon cancer	0.000125	0.000303	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—colon cancer	0.000125	0.000303	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—colon cancer	0.000125	0.000302	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—colon cancer	0.000122	0.000296	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—colon cancer	0.000122	0.000295	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—colon cancer	0.000122	0.000295	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—colon cancer	0.000122	0.000294	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—EP300—colon cancer	0.00012	0.000291	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—colon cancer	0.000119	0.000289	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KRAS—colon cancer	0.000115	0.00028	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—colon cancer	0.000115	0.000278	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KRAS—colon cancer	0.000113	0.000273	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—colon cancer	0.000112	0.000271	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—colon cancer	0.000109	0.000264	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CTNNB1—colon cancer	0.000108	0.000262	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—colon cancer	0.000106	0.000257	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—colon cancer	0.000106	0.000257	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN1A—colon cancer	0.000105	0.000256	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—colon cancer	0.000103	0.000251	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EP300—colon cancer	0.0001	0.000243	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—colon cancer	0.0001	0.000242	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—colon cancer	9.81e-05	0.000238	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SRC—colon cancer	9.76e-05	0.000236	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—colon cancer	9.57e-05	0.000232	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—colon cancer	9.5e-05	0.00023	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NRAS—colon cancer	9.39e-05	0.000227	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—colon cancer	9.38e-05	0.000227	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—colon cancer	8.88e-05	0.000215	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—colon cancer	8.74e-05	0.000212	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—colon cancer	8.72e-05	0.000211	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—colon cancer	8.66e-05	0.00021	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—colon cancer	8.55e-05	0.000207	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—colon cancer	8.45e-05	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KRAS—colon cancer	8.08e-05	0.000196	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—colon cancer	7.42e-05	0.00018	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—colon cancer	7.25e-05	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—colon cancer	7.18e-05	0.000174	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—colon cancer	6.87e-05	0.000166	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—colon cancer	6.06e-05	0.000147	CbGpPWpGaD
